KM PHARMACEUTICAL CO., LTD. – FDA Inspection, Sep 18, 2026

Record Details

This FDA Inspection record concerns KM PHARMACEUTICAL CO., LTD., with an inspection on September 18, 2026, issued by the Office of Inspections and Investigations, covering human drugs.

Company: KM PHARMACEUTICAL CO., LTD.
Inspection Date: September 18, 2026
Product Type: Human Drugs
Office: Office of Inspections and Investigations
People: Damaris Y. Hernandez (Investigator)
Thuy Tram L. Nguyen (Issuing Officer)

View Company Profile

ID · 86079217-0cb2-457e-8c0b-0e7aae7aedb2

Inspection Facts

Inspection number: 1342994
FDA center: Human Drugs
Outcome: Form 483 issued

Other FDA inspections of KM PHARMACEUTICAL CO., LTD.

Date	Classification	Office	Project area
February 22, 2019	VAI	Center for Drug Evaluation and Research	Drug Quality Assurance

Other documents for KM PHARMACEUTICAL CO., LTD.

FDA Inspection 1080318 - 2019-02-22

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore KM PHARMACEUTICAL CO., LTD.

FDA Inspection

KM PHARMACEUTICAL CO., LTD.September 18, 2026

KM PHARMACEUTICAL CO., LTD. – FDA Inspection, Sep 18, 2026

Record Details

This FDA Inspection record concerns KM PHARMACEUTICAL CO., LTD., with an inspection on September 18, 2026, issued by the Office of Inspections and Investigations, covering human drugs.